arrow
D

Debbie L. Shawcross

University of London
H指数:52
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study

代谢功能障碍相关的脂肪性肝病和代谢功能障碍相关的脂肪性肝炎的最佳购买: 全球Delphi研究

2025-12-130
PRE
Erratum to “Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial” [J Infect 91 (2025) 106504]

勘误:“Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial” [J Infect 91 (2025) 106504]

2025-08-140
PREAI
Defining Organ Failures in Patients With Cirrhosis: Consensus Statements

定义肝硬化患者的器官衰竭:共识声明

2025-06-090
PRE
Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use

冻干粪菌胶囊中的细菌多样性、存活能力和稳定性支持其持续的临床应用。

2025-06-010
PRE
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease

靶向抑制致病共生菌毒力因子可缓解酒精性肝病

2025-05-280
PRE
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial

粪菌移植以根除胃肠道中抗生素耐药菌的定植(FERARO):一项可行性随机对照试验

2025-05-160
OA